These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 28164533)
41. The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients. Teng Y; Jiang R; Lin Q; Ding C; Ye Z Thromb Res; 2010 Jul; 126(1):e41-5. PubMed ID: 20226500 [TBL] [Abstract][Full Text] [Related]
42. Alternations of maternal and cord plasma hemostasis in preeclampsia before and after delivery. Xiong Y; Zhou SF; Zhou R; Yang D; Xu ZF; Lou YT; Guo QS; Hu R; Peng T; Ma D; Li XT Hypertens Pregnancy; 2011; 30(3):347-58. PubMed ID: 21174589 [TBL] [Abstract][Full Text] [Related]
43. Flow cytometric investigation of CD40-CD40 ligand system in preeclampsia and normal pregnancy. Lukanov TH; Bojinova SI; Popova VS; Emin AL; Veleva GL; Gecheva SP; Konova EI Clin Appl Thromb Hemost; 2010 Jun; 16(3):306-12. PubMed ID: 19221099 [TBL] [Abstract][Full Text] [Related]
44. Preeclampsia: integrated network model of platelet biomarkers interaction as a tool to evaluate the hemostatic/immunological interface. Freitas LG; Sathler-Avelar R; Vitelli-Avelar DM; Bela SR; Teixeira-Carvalho A; Carvalho Md; Martins-Filho OA; Dusse LM Clin Chim Acta; 2014 Sep; 436():193-201. PubMed ID: 24909876 [TBL] [Abstract][Full Text] [Related]
45. Tissue factor expression by monocytes: regulation and pathophysiological roles. Osterud B Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S9-14. PubMed ID: 9819023 [TBL] [Abstract][Full Text] [Related]
46. Thrombin activation of endometrial endothelial cells: a possible role in intrauterine growth restriction. Krikun G; Huang ST; Schatz F; Salafia C; Stocco C; Lockwood CJ Thromb Haemost; 2007 Feb; 97(2):245-53. PubMed ID: 17264954 [TBL] [Abstract][Full Text] [Related]
47. Intravascular tissue factor pathway--a model for rapid initiation of coagulation within the blood vessel. Engelmann B; Luther T; Müller I Thromb Haemost; 2003 Jan; 89(1):3-8. PubMed ID: 12540946 [TBL] [Abstract][Full Text] [Related]
48. Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation. Keuren JF; Magdeleyns EJ; Govers-Riemslag JW; Lindhout T; Curvers J Br J Haematol; 2006 Aug; 134(3):307-13. PubMed ID: 16848773 [TBL] [Abstract][Full Text] [Related]
49. Dilazep and dipyridamole inhibit tissue factor expression on monocytes induced by IgG from patients with antiphospholipid syndrome. Zhou H Acta Pharmacol Sin; 2004 Oct; 25(10):1366-71. PubMed ID: 15456541 [TBL] [Abstract][Full Text] [Related]
50. Monocytes and plasma tissue factor levels in normal individuals and patients with deep venous thrombosis of the lower limbs: potential diagnostic tools? Vieira LM; Dusse LM; Fernandes AP; Martins-Filho OA; de Bastos M; Ferreira MF; Cooper AJ; Lwaleed BA; Carvalho MG Thromb Res; 2007; 119(2):157-65. PubMed ID: 16527335 [TBL] [Abstract][Full Text] [Related]
51. Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies. Donohoe S; Quenby S; Mackie I; Panal G; Farquharson R; Malia R; Kingdom J; Machin S Lupus; 2002; 11(1):11-20. PubMed ID: 11898913 [TBL] [Abstract][Full Text] [Related]
52. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer. Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160 [TBL] [Abstract][Full Text] [Related]
53. Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations. Chaturvedi S; Cockrell E; Espinola R; Hsi L; Fulton S; Khan M; Li L; Fonseca F; Kundu S; McCrae KR Thromb Res; 2015 Jan; 135(1):102-8. PubMed ID: 25467081 [TBL] [Abstract][Full Text] [Related]
54. Human platelets do not express tissue factor. Østerud B; Olsen JO Thromb Res; 2013 Jul; 132(1):112-5. PubMed ID: 23623171 [TBL] [Abstract][Full Text] [Related]
55. Differential ability of tissue factor antibody clones on detection of tissue factor in blood cells and microparticles. Basavaraj MG; Olsen JO; Østerud B; Hansen JB Thromb Res; 2012 Sep; 130(3):538-46. PubMed ID: 22728024 [TBL] [Abstract][Full Text] [Related]
57. Changes of plasma tissue factor and tissue factor pathway inhibitor antigen levels and induction of tissue factor expression on the monocytes in coronary artery disease. Kim HK; Song KS; Park YS; Yun YS; Shim WH Cardiology; 2000; 93(1-2):31-6. PubMed ID: 10894904 [TBL] [Abstract][Full Text] [Related]
58. Anti-tissue factor pathway inhibitor activity in subjects with antiphospholipid syndrome is associated with increased thrombin generation. Adams M; Breckler L; Stevens P; Thom J; Baker R; Oostryck R Haematologica; 2004 Aug; 89(8):985-90. PubMed ID: 15339683 [TBL] [Abstract][Full Text] [Related]
59. Tissue factor-dependent pathway in severe preeclampsia revisited: a Brazilian cohort study. Dusse LM; Godoi LC; Gomes KB; Carvalho Md; Lwaleed BA Blood Coagul Fibrinolysis; 2016 Jun; 27(4):436-40. PubMed ID: 26765308 [TBL] [Abstract][Full Text] [Related]
60. Identification of anti-moesin antibodies in the serums of patients with antiphospholipid syndrome. Lin X; Liang Q; Lin L; Ding Q; Wang X; Wang Y Thromb Res; 2015 May; 135(5):867-72. PubMed ID: 25743886 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]